Aragen extends partnership with NeoVac for lipid product

Aragen Life Sciences Private Limited announced that it has entered into an agreement with UK-based firm, NeoVac, for manufacturing a lipid product that will support the development of lipid nanoparticles (LNP) for use in developing RNA vaccines...

TATA model to be replicated in KSSSCI, Lucknow

The Tata Memorial Hospital (TMH) operating model will be replicated by the Kalyan Singh Super Specialty Cancer Institute (KSSSCI) in Mumbai. The effort is to learn the TMH model of functioning so that it can be replicated at KSSSCI. The director a...

Pharmaceutical R&D Progressing Toward Predictive Analysis

Since the COVID-19 pandemic first impacted the life science industry around the world, Pharmaceutical R&D spending has reached over $200 billion each year — and it’s projected to surpass $250 billion by 2026. Rising expenditure patterns indicate

Harnessing The Power Of Data Science For Effective Drug Development

Modern drug discovery heavily relies on predictive analysis, artificial intelligence and machine learning. In order to boost innovation in drug discovery, a lot of big pharma and biotech businesses are turning to data science. Utilization of data ana

Healthcare-Information Security Aspects

Information Security is a critical requirement in the Bank¬ing and Healthcare industry. News abounds about data theft and breaches affecting millions of customers. With increasing threat vectors and rising intensity of attacks it is im¬portant that w

Ai, Cloud Computing & Iot For Healthcare In India & The Path Ahead

Healthcare is one of the fast¬est growing sectors in India and it is relatively offering a lower priced treatment options that provide a great opportunity for the growth of various segments across the industry – medical devices, pharmaceutical manuf

Indian Pharmaceutical Industry & Its Global Impact

As of today, around 70 percent of critical Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) are imported. The PLlscheme is meant for promotion of domestic manufacturing of critical KSMs, Drug intermediates and APIs in India

Lessons Learned From This Pandemic In The Healthcare Sector & The Roadmap Ahead For India

The last year has been a whirl¬wind for the entire world, courtesy of the COVID-19 pan¬demic. With markets plummeting, businesses shutting down and indi¬viduals scampering to keep them¬selves safe, there has been a drastic change in industries

Understanding Precision Oncology & Targeted Therapies for Cancer Patients

I ndia sees more than a million cases of cancer every year. While, countless efforts are being made all over the world to find a cure for this life-threating disease, we believe Precision Oncology can be the game changer in this direction.

Non-Invasive Natural Bypass Technique Can Treat Various Heart Conditions

A ttributing to increase in changing lifestyle, people of¬ten miss out on taking care of their health as a result of which there is an exponential increase of non-communicable diseases among the middle-aged population in the last decade.

© 2025 India Pharma Outlook. All Rights Reserved.